IDev's peripheral vessel nitinol stent:
This article was originally published in Clinica
IDev Technologies, has CE-marked for sale in Europe its nitinol stent for treating peripheral vascular and non-vascular diseases. The device, which is self-expandable, has a significant radial force that is resistant to kinking, crushing and fracture potential. It also comprises a delivery system that allows it to be placed precisely and repositioned prior to deployment, said the Houston, Texas firm.
You may also be interested in...
Butterfly Network chose SPAC route with Longview Acquisition Corp. to scale its business and expand into the home market in 2021.
Regulatory review resource-intensive cell and gene therapy licensing applications are rolling toward US FDA along expedited pathways, while complete response letters and missed goal dates start to stack up under pandemic inspection constraints.
With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says
As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.